# Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes

> **NCT00006305** · PHASE3 · COMPLETED · sponsor: **University of Pittsburgh** · enrollment: 2368 (actual)

## Conditions studied

- Coronary Disease
- Cardiovascular Diseases
- Heart Diseases
- Insulin Resistance
- Diabetes Mellitus
- Diabetes Mellitus, Non-Insulin-Dependent

## Interventions

- **PROCEDURE:** Angioplasty, Transluminal, Percutaneous Coronary, other catheter-based interventions
- **PROCEDURE:** Coronary Artery Bypass
- **DRUG:** Biguanides, thiazolidinediones
- **DRUG:** Insulin, sulfonylurea
- **DRUG:** ACE Inhibitors, Angiotensin Receptor Blockers, Beta Blockers, Calcium Channel Blockers

## Key facts

- **NCT ID:** NCT00006305
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-09
- **Primary completion:** 2008-11
- **Final completion:** 2009-03
- **Target enrollment:** 2368 (ACTUAL)
- **Last updated:** 2016-02-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006305, "Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00006305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*